Franklin Resources
FLNA

Franklin Resources’s Filana Therapeutics FLNA Stock Holding History

Franklin Resources’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,167
Closed -$24K – 3052
2024
Q4 		$24K Sell
10,167
-1,433
-12% -$25.2K ﹤0.01% 2845
2024
Q3 		$319K Sell
11,600
-10,278
-47% -$237K ﹤0.01% 2465
2024
Q2 		$270K Buy
21,878
+2,734
+14% +$57.6K ﹤0.01% 2466
2024
Q1 		$388K Sell
19,144
-27
-0.1% -$622 ﹤0.01% 2363
2023
Q4 		$432K Buy
+19,171
New +$405K ﹤0.01% 2014
2023
Q3 		– Sell
-8,408
Closed -$206K – 2769
2023
Q2 		$206K Buy
+8,408
New +$202K ﹤0.01% 2368

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources's FLNA Position: Q1 2025 in Review

Franklin Resources sold out of Filana Therapeutics (FLNA) in Q1 2025, closing a stake of 10,167 shares — an estimated $24K sold.

Franklin Resources first reported a position in FLNA in Q2 2023 and held it in 6 quarters. The position peaked at $432K in Q4 2023. 117 funds tracked by Wall St. Rank hold FLNA as of Q1 2025.

  • Franklin Resources reported no remaining Filana Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Franklin Resources sold 10,167 Filana Therapeutics shares in Q1 2025, an estimated $24K.
  • Franklin Resources first reported a position in Filana Therapeutics in Q2 2023 and held it in 6 quarters.
  • Franklin Resources's Filana Therapeutics position peaked at $432K in Q4 2023.
  • 117 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2025.

Based on Franklin Resources's 13F filing for Q1 2025, filed 13 May 2025.